The Lung Cancer Channel is supported with funding from Johnson & Johnson (Gold) and Takeda (Gold).
VJOncology is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.
VJVirtual | The Route Back to 25 by 25: UKLCC strategy to improve lung cancer care in UK
Robert Rintoul, PhD, FRCP, University of Cambridge and Royal Papworth Hospital NHS Foundation Trust, Cambridge; Chair of the UK Lung Cancer Coalition Clinical Advisory Group discusses the report released by the UKLCC in November 2021 about strategies to increase 5 year survival for patients with lung cancer in the UK to 25% by 2025. The COVID-19 pandemic has caused a large shift backwards in 5 year survival for patients with lung cancer, so this report outlines the urgent need for improvements in this area.
